# FDA Inspection 1258760 - Smithers Pharmaceutical Development Services - December 13, 2024

Source: https://www.keypedia.com/records/fda_inspections/smithers-pharmaceutical-development-services/1849cd4a-d7ff-4b60-8e1f-5bbdf6ccee21
Source feed: FDA_Inspections

> FDA Inspection 1258760 for Smithers Pharmaceutical Development Services on December 13, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1258760
- Company Name: Smithers Pharmaceutical Development Services
- Inspection Date: 2024-12-13
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1258760 - 2024-12-13](https://www.keypedia.com/records/fda_inspections/smithers-pharmaceutical-development-services/87c212b3-8aec-4e47-85e1-3cf3bf1af9e1)

Company: https://www.keypedia.com/companies/smithers-pharmaceutical-development-services/8d64b2e6-5478-4d49-988c-1b15e8fa6c25

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c